×
Jeśli w ciągu kilku sekund nie nastąpi przekierowanie, kliknij
tutaj
.
Wszystko
Grafika
Wideo
Wiadomości
Mapy
Zakupy
Książki
Narzędzia wyszukiwania
Szukaj w internecie
Szukaj w internecie
Tylko język polski
Najnowsze
Najnowsze
Ostatnia godzina
Ostatnie 24 godziny
Ostatni tydzień
Ostatni miesiąc
Ostatni rok
Archiwa
Według trafności
Według trafności
Według daty
Dr Binod Dhakal Discusses Game-Changing Cilta-Cel Approval for RRMM
AJMC
Binod Dhakal, MD, associate professor, Medical College of Wisconsin, is lead investigator of the CARTITUDE-4 study, from which data were...
19 godzin temu
FDA rejects Abeona' Therapeutics' topical gene therapy pz-cel
Fierce Pharma
The FDA has rejected Abeona Therapeutics' gene therapy pz-cel, specifying chemistry, manufacturing and controls (CMC) issues that must be...
dzień temu
FDA Issues Complete Response Letter for Abeona's Pz-cel for Epidermolysis Bullosa
Dermatology Times
The CRL indicates that the timing proposed for data submission would not allow enough time for the FDA to complete its review by the May 25...
dzień temu
Axi-Cel in LBCL Among Different Races and Ethnicities: Real-World and Clinical Trial Outcomes
Physician's Weekly
The following is a summary of "Real-World and Clinical Trial Outcomes in Large B-cell Lymphoma with Axicabtagene Ciloleucel Across Race and...
15 godzin temu
European Commission Approves Cilta-Cel for R/R Myeloma After at Least 1 Prior Line of Therapy
OncLive
Cilta-cel has received approval from the European Commission for multiple myeloma that is relapsed or refractory to at least 1 prior line of...
2 dni temu
CRL issued for pz-cel as potential recessive dystrophic epidermolysis bullosa treatment
Contemporary Pediatrics
Abeona's pz-cel is up for indicated use to treat patients with recessive dystrophic epidermolysis bullosa.
dzień temu
CEL-SCI Appoints Mario Gobbo to Its Board of Directors
Business Wire
VIENNA, Va.--(BUSINESS WIRE)--CEL-SCI Corporation (NYSE American: CVM) today announced the appointment of Mario Gobbo to its Board of...
dzień temu
Abeona Therapeutics Provides Regulatory Update on Pz-cel
GlobeNewswire
Receives FDA Complete Response Letter (CRL) based on need for additional CMC information CRL did not identify deficiencies related to...
2 dni temu
5 Cell and Gene Therapy Decisions to Watch in 2024
BioSpace
From gene-corrected cell therapies to a new CAR-T, the cell and gene therapy space looks to expand its reach into the market.
3 dni temu
Cel-Sci Corp Bolsters Board with Finance Expert Mario Gobbo - TipRanks.com
Tipranks
Cel-Sci Corp. (CVM) has shared an announcement. CEL-SCI Corporation has enhanced its Board of Directors with the appointment of Mario Gobbo,...
dzień temu